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Lung cancer remains the most common cancer-related cause of 
death among American men and women. More than one in four 
cases of all diagnosed cancers involves the lung. By the end of the 
year 2008, there will be over 215,000 new cases of lung cancer 
(for the year) and over 161,000 deaths from lung cancer. 
Over the course of the past several decades, we have made only 
a few small strides in our fight against lung cancer, in spite of 
significant efforts put in by the medical research community. 
The overall five-year survival for lung cancer still remains lower 
than 20%.  In the era of molecularly targeted therapies, new 
drugs, specifically the drugs that target the EGFR and the VEGF 
pathways, have been developed against lung cancer. Even with 
these novel therapies, the overall survival rate remains poor, 
especially in the case of metastatic lung cancer. 
Lung cancer is a no longer a disease affecting smokers alone. 
About 15% of lung cancer patients around the world are non-
smokers, and a significant portion of them are women. The 
incidence of lung cancer is on the rise among white women 
and African American men and women. These observations 
suggest the need to understand the processes and mechanisms 
of carcinogenesis for different population. 
The “philosophy” of “personalized therapies” to treat cancers 
is gaining momentum with the success of targeted therapies 
and the trend is slowly catching-up for the treatment of lung 
cancer as well.
Most cancers, including lung cancer, are preventable. Awareness 
about cancer and cancer prevention are critical for reducing 
cancer related deaths in the world.  The knowledge of genesis of 
the cancers can empower people to adapt lifestyles that reduce 
the risk for cancer incidence. 
November is observed as ‘Lung Cancer Awareness’ month 
worldwide, providing an opportunity to the biomedical research 
community to focus on developing diagnostic, preventive 
and treatment strategies to combat lung cancers. It takes a 
“community” to achieve this goal and the Carcinogenesis Research 
Community should be in the forefront of such an effort. 
In observance of ‘Lung Cancer Awareness’ month, the Journal of 
Carcinogenesis solicits original research and review articles that 
address lung carcinogenesis.  The journal encourages authors to 
submit articles that are related to secondhand smoking and lung 
carcinogenesis, and lung carcinogenesis mechanisms among 
non-smokers, especially women. 
The Journal of Carcinogenesis is committed to lead the 
Carcinogenesis Research Community in the efforts to ‘Stamp 
Out Lung Cancer’. Please publish your research in the journal 
and support the cause to eradicate lung cancer. 
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